2656 STATE STREET, CARLSBAD, CA
Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Other Events
Election of Three Directors at Tyra Biosciences 2026 Annual Meeting
Reports First Quarter 2026 Financial Results and Recent Highlights
Board Appointment - Habib J. Dable Joins Tyra Biosciences Board
Annual Report to Security Holders
Julia Rueb Appointed Principal Accounting Officer at Tyra Biosciences
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Free Writing Prospectus
Correspondence
Submission Upload